Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,191 | 151 | 80.0% |
| Consulting Fee | $735.00 | 1 | 18.4% |
| Education | $64.99 | 1 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABIOMED | $1,353 | 61 | $0 (2024) |
| Kestra Medical Technology Services, Inc. | $1,112 | 23 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $462.72 | 38 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $319.03 | 10 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $279.93 | 13 | $0 (2024) |
| Boston Scientific Corporation | $207.40 | 3 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $142.10 | 2 | $0 (2024) |
| Medtronic, Inc. | $71.83 | 1 | $0 (2021) |
| Chiesi USA, Inc. | $25.12 | 1 | $0 (2024) |
| SCPHARMACEUTICALS INC. | $16.93 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,803 | 48 | Kestra Medical Technology Services, Inc. ($1,018) |
| 2023 | $950.18 | 44 | ABIOMED ($358.18) |
| 2022 | $761.00 | 34 | ABIOMED ($360.91) |
| 2021 | $476.31 | 27 | ABIOMED ($229.44) |
All Payment Transactions
153 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $6.04 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/10/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $16.36 | General |
| Category: Cardiology | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $11.01 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/15/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $133.23 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/14/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $68.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/12/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $17.11 | General |
| Category: Cardiology | ||||||
| 11/01/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/23/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $22.30 | General |
| Category: Cardiology | ||||||
| 10/23/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $20.05 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/22/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $6.46 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/17/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $19.67 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $6.19 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/10/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $19.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/04/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $106.54 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 09/25/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $2.89 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/19/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $11.26 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/17/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $13.89 | General |
| Category: Cardiology | ||||||
| 08/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $6.52 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/26/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $11.22 | General |
| Category: Cardiology | ||||||
| 06/28/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Consulting Fee | Cash or cash equivalent | $735.00 | General |
| Category: Cardiology | ||||||
| 06/19/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $31.13 | General |
| Category: Cardiology | ||||||
| 06/17/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $24.10 | General |
| Category: Cardiology | ||||||
| 05/21/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $7.22 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 175 | 304 | $57,338 | $21,342 |
| 2022 | 5 | 210 | 346 | $68,740 | $21,831 |
| 2021 | 6 | 271 | 373 | $68,982 | $22,897 |
| 2020 | 4 | 235 | 313 | $57,876 | $19,888 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 94 | 199 | $40,198 | $15,504 | 38.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 61 | 85 | $12,240 | $4,344 | 35.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 20 | 20 | $4,900 | $1,494 | 30.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 98 | 213 | $43,026 | $14,116 | 32.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 49 | 69 | $9,936 | $3,161 | 31.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 30 | 30 | $7,350 | $2,042 | 27.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 16 | 16 | $4,864 | $1,414 | 29.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 17 | 18 | $3,564 | $1,098 | 30.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 113 | 193 | $38,986 | $12,865 | 33.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 80 | 98 | $14,112 | $4,490 | 31.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 28 | 31 | $4,352 | $2,026 | 46.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 26 | 27 | $6,615 | $1,894 | 28.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 12 | 12 | $3,648 | $1,082 | 29.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 12 | 12 | $1,269 | $540.72 | 42.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 133 | 190 | $38,380 | $13,396 | 34.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 68 | 88 | $12,672 | $4,268 | 33.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 18 | 18 | $4,410 | $1,311 | 29.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 16 | 17 | $2,414 | $913.63 | 37.8% |
About Jacquelyn Prokop, PA
Jacquelyn Prokop, PA is a Physician Assistant healthcare provider based in Midland, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/12/2016. The National Provider Identifier (NPI) number assigned to this provider is 1144778812.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jacquelyn Prokop, PA has received a total of $3,991 in payments from pharmaceutical and medical device companies, with $1,803 received in 2024. These payments were reported across 153 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($3,191).
As a Medicare-enrolled provider, Prokop has provided services to 891 Medicare beneficiaries, totaling 1,336 services with total Medicare billing of $85,958. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Midland, MI
- Active Since 09/12/2016
- Last Updated 01/22/2019
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1144778812
Products in Payments
- Impella (Device) $1,353
- Assure WCD (Device) $1,112
- XARELTO (Drug) $319.03
- ENTRESTO (Drug) $302.34
- LifeVest (Device) $279.93
- LEQVIO (Drug) $160.38
- WATCHMAN FLX (Device) $106.54
- WATCHMAN Access System (Device) $100.86
- FARXIGA (Drug) $77.11
- Micra (Device) $71.83
- ATACAND (Drug) $64.99
- CLEVIPREX (Drug) $25.12
- FUROSCIX (Drug) $16.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Midland
Samuel Baumguardner, Pa-C, PA-C
Physician Assistant — Payments: $14,403
Mrs. Pamela Foster, Pa, PA
Physician Assistant — Payments: $12,205
Salwa Mohamedaman
Physician Assistant — Payments: $8,438
Mr. Christopher Vela, Pac, PAC
Physician Assistant — Payments: $7,196
Alison Smith, Pa, PA
Physician Assistant — Payments: $7,100
Stephanie Johnson
Physician Assistant — Payments: $7,043